Original source: SimoleonSense.com .
If you like Atul Gawande you will enjoy this…
Introduction (via Stephanie Saul @ NYT)
Like most women, Ms. Long had regarded the breast biopsy as the gold standard, an infallible way to identify cancer. “I thought it was pretty cut and dried,” said Ms. Long, who is a registered nurse.
As it turns out, diagnosing the earliest stage of breast cancer can be surprisingly difficult, prone to both outright error and case-by-case disagreement over whether a cluster of cells is benign or malignant, according to an examination of breast cancer cases by The New York Times.
Advances in mammography and other imaging technology over the past 30 years have meant that pathologists must render opinions on ever smaller breast lesions, some the size of a few grains of salt. Discerning the difference between some benign lesions and early stage breast cancer is a particularly challenging area of pathology, according to medical records and interviews with doctors and patients.
Click Here To Read: Decision Making, Error Rates, and Detecting Cancer
- Famous Psychologist Daniel Gilbert: Why The Brain Talks To Itself: Sources Of Error In Emotional Prediction
- Contagious Speculation and a Cure for Cancer: A Nonevent that Made Stock Prices Soar
- One-reason decision making in risky choice? A closer look at the priority heuristic
- Behavioural Economics and Complex Decision-Making Implications for the Australian Tax and Transfer System
Alphaverse.com uses this content with author’s permission purely for educational purposes. Go to the feed source of this article
